Compare BV & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BV | CDNA |
|---|---|---|
| Founded | 1939 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2018 | 2007 |
| Metric | BV | CDNA |
|---|---|---|
| Price | $12.13 | $22.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $14.50 | ★ $27.33 |
| AVG Volume (30 Days) | 421.7K | ★ 557.8K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $48,324,000.00 |
| Revenue This Year | $4.61 | $16.01 |
| Revenue Next Year | $1.90 | $11.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 18.93 |
| 52 Week Low | $11.06 | $10.96 |
| 52 Week High | $17.11 | $21.49 |
| Indicator | BV | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 52.36 | 71.47 |
| Support Level | $11.29 | $16.63 |
| Resistance Level | $12.47 | N/A |
| Average True Range (ATR) | 0.29 | 1.13 |
| MACD | 0.11 | 0.38 |
| Stochastic Oscillator | 81.72 | 95.45 |
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.